BMS-201620: a selective beta 3 agonistWilliam N. Washburn, Andrea A. Seymour, C Sun et al.|Bioorganic & Medicinal Chemistry Letters|2004Cited by 16
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic PropertiesMatthew D. Hill, Andrew P. Degnan, Claude Quesnelle et al.|ACS Medicinal Chemistry Letters|2022Cited by 10
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotypeMatthew D. Hill, Andrew P. Degnan, Claude Quesnelle et al.|Bioorganic & Medicinal Chemistry Letters|2021Cited by 6